Stock Research: Merck (USA)

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Merck (USA)

NYSE:MRK US58933Y1055
66
  • Value
    50
  • Growth
    48
  • Safety
    Safety
    86
  • Combined
    73
  • Sentiment
    50
  • 360° View
    360° View
    66
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Merck & Co., Inc. is a global healthcare company providing health solutions through prescription medicines, vaccines, and animal health products. It operates in the pharmaceutical and animal health industries. The company sells its products globally. In the last fiscal year, the company had a market cap of $204699 million, profits of $49470 million, revenue of $64168 million, and 75000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 66 (better than 66% compared with alternatives), overall professional sentiment and financial characteristics for the stock Merck (USA) are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Merck (USA). The consolidated Value Rank has an attractive rank of 86, which means that the share price of Merck (USA) is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 86% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 50. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 50. But the consolidated Growth Rank has a low rank of 48, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 52 of its competitors have better growth. ...read more

more
Index
Dow Jones
Dividends USA
Diversity USA
D.J. US Pharmaceutical
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
86 84 60 81
Growth
48 39 43 59
Safety
Safety
50 42 46 94
Sentiment
50 34 88 96
360° View
360° View
66 28 73 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
23 39 57 27
Opinions Change
49 15 50 83
Pro Holdings
n/a 86 96 96
Market Pulse
31 37 74 72
Sentiment
50 34 88 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
86 84 60 81
Growth
48 39 43 59
Safety Safety
50 42 46 94
Combined
73 47 44 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
71 77 65 88
Price vs. Earnings (P/E)
39 32 24 36
Price vs. Book (P/B)
31 32 10 12
Dividend Yield
98 96 89 94
Value
86 84 60 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
46 49 56 51
Profit Growth
50 56 10 62
Capital Growth
47 40 56 32
Stock Returns
36 27 59 73
Growth
48 39 43 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
38 31 45 34
Refinancing
22 10 23 95
Liquidity
89 94 82 89
Safety Safety
50 42 46 94

Similar Stocks

Discover high‑ranked alternatives to Merck (USA) and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

PriceSmart

NasdaqGS:PSMT
Country: USA
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.